Obesity and Co-morbid Conditions Are Associated with Specific Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Ashley H Sanderlin, David Todem, Andrea C Bozoki
Author Information
  1. Ashley H Sanderlin: Neuroscience Program, Michigan State University, East LansingMI, United States.
  2. David Todem: Division of Biostatistics, Department of Epidemiology and Biostatistics, Michigan State University, East LansingMI, United States.
  3. Andrea C Bozoki: Neuroscience Program, Michigan State University, East LansingMI, United States.

Abstract

Neuropsychiatric symptoms (NPSs) in MCI, and midlife obesity increase the likelihood of developing Alzheimer's disease. It is unknown whether obesity or related health conditions modify the risk of NPS or severity of cognitive impairment in MCI. One hundred and thirteen subjects with MCI were assessed near the time of MCI diagnosis. The sample was divided by BMI and related disorders, type-2 diabetes (T2D) and obstructive sleep apnea (OSA) to measure the relationship of these groups with NPS and severity of MCI. NPSs scores were evaluated based on the Neuropsychiatric Inventory-Questionnaire (NPI-Q) and Geriatric Depression Scale, along with NPI-Q clusters. MCI-severity was estimated based on a composite z-score of neuropsychological tests. Obese and overweight subjects represented 65% of the sample and were on average 7 years younger than normal weight subjects. The presence of obesity, T2D and OSA status modified the prevalence and severity of specific NPI-Q symptom clusters, specifically affective symptoms were more frequent across groups and severe in OB and T2D. Total NPS scores were higher for subjects with T2D and OSA although MCI-severity did not differ across groups. MCI subjects with obesity, T2D and OSA demonstrated a higher susceptibility to psychopathologic changes.

Keywords

References

  1. Dement Geriatr Cogn Disord. 2008;25(2):115-26 [PMID: 18087152]
  2. Neurology. 2007 May 8;68(19):1596-602 [PMID: 17485646]
  3. Arch Gen Psychiatry. 2010 Mar;67(3):220-9 [PMID: 20194822]
  4. Lancet Neurol. 2006 Aug;5(8):713-20 [PMID: 16857578]
  5. Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95 [PMID: 23567400]
  6. Arch Gen Psychiatry. 2012 Apr;69(4):410-7 [PMID: 22147809]
  7. Neurology. 1989 Sep;39(9):1159-65 [PMID: 2771064]
  8. Arch Clin Neuropsychol. 2004 Mar;19(2):203-14 [PMID: 15010086]
  9. Arch Gen Psychiatry. 2008 Oct;65(10):1193-8 [PMID: 18838636]
  10. Obes Rev. 2008 May;9(3):204-18 [PMID: 18331422]
  11. Brain Res Bull. 2012 Nov 1;89(3-4):144-9 [PMID: 22921944]
  12. Front Endocrinol (Lausanne). 2014 May 15;5:74 [PMID: 24860551]
  13. Br Med Bull. 2011;97:169-96 [PMID: 21325341]
  14. J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9 [PMID: 11001602]
  15. Arch Neurol. 1999 Mar;56(3):303-8 [PMID: 10190820]
  16. Int J Geriatr Psychiatry. 2011 Apr;26(4):364-72 [PMID: 20845402]
  17. Int J Geriatr Psychiatry. 2014 Feb;29(2):153-9 [PMID: 23681754]
  18. Biochim Biophys Acta. 2017 May;1863(5):1078-1089 [PMID: 27567931]
  19. Int J Geriatr Psychiatry. 2005 Jun;20(6):531-6 [PMID: 15920706]
  20. Int J Obes (Lond). 2013 Sep;37(9):1183-91 [PMID: 23229740]
  21. J Psychiatr Res. 1975 Nov;12(3):189-98 [PMID: 1202204]
  22. Dement Geriatr Cogn Disord. 2007;24(6):457-63 [PMID: 17986816]
  23. Dement Geriatr Cogn Disord. 2007;24(4):253-9 [PMID: 17700021]
  24. JAMA. 2002 Sep 25;288(12):1475-83 [PMID: 12243634]
  25. J Diabetes Res. 2014;2014:179648 [PMID: 25431771]
  26. Alzheimers Dement. 2016 Feb;12 (2):195-202 [PMID: 26096665]
  27. J Clin Psychiatry. 1987 Aug;48(8):314-8 [PMID: 3611032]
  28. JAMA. 2014 Feb 26;311(8):806-14 [PMID: 24570244]
  29. Arch Gen Psychiatry. 2006 Jul;63(7):824-30 [PMID: 16818872]
  30. Eur J Pharmacol. 2008 May 6;585(1):163-75 [PMID: 18423446]
  31. Neurology. 2010 Jan 19;74(3):201-9 [PMID: 20042704]
  32. Neurology. 2011 Apr 26;76(17):1485-91 [PMID: 21490316]
  33. Eur Respir J. 2011 Jul;38(1):98-105 [PMID: 21406511]
  34. Neurology. 2008 Sep 30;71(14):1057-64 [PMID: 18367704]
  35. JAMA. 2010 Jan 20;303(3):235-41 [PMID: 20071471]
  36. Sci Am. 1971 Aug;225(2):82-90 [PMID: 5089457]
  37. Am J Psychiatry. 1984 Nov;141(11):1356-64 [PMID: 6496779]
  38. J Affect Disord. 2016 Jan 15;190:264-71 [PMID: 26540080]

Word Cloud

Created with Highcharts 10.0.0MCIobesitysubjectsT2DOSANeuropsychiatricsymptomsNPSseveritygroupsNPI-QNPSsdiseaserelatedcognitiveimpairmentsamplediabetesscoresbasedclustersMCI-severityacrosshighermidlifeincreaselikelihooddevelopingAlzheimer'sunknownwhetherhealthconditionsmodifyriskOnehundredthirteenassessedneartimediagnosisdividedBMIdisorderstype-2obstructivesleepapneameasurerelationshipevaluatedInventory-QuestionnaireGeriatricDepressionScalealongestimatedcompositez-scoreneuropsychologicaltestsObeseoverweightrepresented65%average7yearsyoungernormalweightpresencestatusmodifiedprevalencespecificsymptomspecificallyaffectivefrequentsevereOBTotalalthoughdifferdemonstratedsusceptibilitypsychopathologicchangesObesityCo-morbidConditionsAssociatedSpecificSymptomsMildCognitiveImpairmentAlzheimer’sbehavioralmildtype2

Similar Articles

Cited By